FDA Drug Shortages

Current and Resolved Drug Shortages and Discontinuations Reported to FDA

Start Over | Back to Previous Screen

Rifampin Capsules
Status: Discontinuation
»Therapeutic Categories: Anti-Infective

Expand all

Lannett Company, Inc. (New 02/02/2021)

Company Contact Information:
215-333-9000

Presentation Posting Date Related Information
150 mg )NDC 0527-1393-30) 02/02/2021 Lannett has made a business decision to discontinue the drug product.
150 mg (NDC 0527-1393-01) 02/02/2021 Lannett has made a business decision to discontinue the drug product.
300 mg (NDC 0527-1315-30) 02/02/2021 Lannett has made a business decision to discontinue the drug product.
300 mg (NDC 0527-1315-06) 02/02/2021 Lannett has made a business decision to discontinue the drug product.
300 mg (NDC 0527-1315-01) 02/02/2021 Lannett has made a business decision to discontinue the drug product.

Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English